Abstract 13919: Ticagrelor versus Clopidogrel in Patients With Acute Coronary Syndrome: A Meta-Analysis
2021
Introduction: P2Y12 receptor antagonists are potent antiplatelet medications used in acute coronary syndrome (ACS). As compared to clopidogrel, ticagrelor has been shown to decrease the risk of myo...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI